Companies: 10,795·Total market cap: $144.5T
ImmuPharma plc

ImmuPharma plc

IMMPFOTCHealthcare
$0.09
+$0.00(+0.00%)
Market Cap$28339256
P/E Ratio—
52W High$0.085
52W Low$0.08
EarningsFinancialsRevenue

ImmuPharma plc (IMMPF) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

IMMPF · earnings · updated Jun 8, 2026

No earnings history available.

Next Earnings Date

Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
No earnings history available.
No analyst estimates available for IMMPF.

About Earnings & Data Methodology

Data source: Financial Modeling Prep (FMP)  |  Updated: Hourly  |  Surprise%: (Actual − Estimate) / |Estimate| × 100  |  Fiscal year: IMMPF ends December

ImmuPharma plc (IMMPF) reports earnings quarterly as a OTC-listed Biotechnology company. The next IMMPF earnings date is expected around September 1, 2026.

Each quarter, investors track IMMPF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. IMMPF revenue tab →

Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
IMMPF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
RevenuePrice historyFinancial statementsForecastDividendsMarket cap

Frequently asked questions

IMMPF earnings · 3 questions

ImmuPharma plc's next earnings report is expected around September 1, 2026. IMMPF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; IMMPF historically reports after market close (AMC).

IMMPF earnings datewhen is IMMPF earningsIMMPF next earnings datewhen does IMMPF report earningsIMMPF earnings calendar

▸ Source: FMP · ImmuPharma plc SEC filings · US GAAP · ImmuPharma plc SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026